Desmoglein 3-ELISA: A pemphigus vulgaris-specific diagnostic tool

Archives of Dermatology

Volumn 135, Issue 2, 1999, Pages 143-148

  Lenz, Petra ^a   Amagai, Masayuki ^b   Volc Platzer, Beatrix ^a   Stingl, Georg ^a   Kirnbauer, Reinhard ^a  

^a Universitatsklinik fur Dermatologie   (Austria)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DESMOGLEIN;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PEMPHIGUS VULGARIS; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; AUTOANTIGENS; CADHERINS; DESMOGLEIN 3; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PEMPHIGUS;

EID: 0032980595     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Stanley JR, Pemphigus. In: Fitzpatrick TB, Eisen AZ, Wollf K, Freeberg IM, Austen KF, eds. Dermatology in General Medicine. New York, NY: MacGraw-Hill Book Co: 1993:606-615.
2. Amagai M, Karpati S, Prussick R, Klaus-Kovtun V, Stanley JR. Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. J Clin Invest 1992;90:919-926.
3. Amagai M, Hashimoto T, Shimizu N, Nishikawa T. Absorption of pathogenic auto antibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. J Clin Invest. 1994;94:59-67.
4. Amagai M, Koch PJ, Nishikawa T, Stanley JR. Pemphigus vulgaris antigen (Desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients. J Invest Dermatol. 1996;106:351.
5. Amagai M, Klaus-Kovtun V, Stanley JR. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell. 1991;67: 869-877.
6. Amagai M, Karpati S, Klaus-Kovtun V, Udey MC, Stanley JR. Extracellular domain of pemphigus vulgaris antigen (desmoglein 3) mediates weak homophilic adhesion. J Invest Dermatol. 1994;102:402-408.
7. Anhalt GJ, Labib RS, Voorhees JJ, Beals TF, Diaz LA. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med. 1982;306:1189-1196.
8. Schiltz JR, Michel B. Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum. J Invest Dermatol. 1976;67: 254-260.
9. Farb RM, Dykes R, Lazarus GS. Anti-epidermal-cell-surface pemphigus antibody detaches viable epidermal cells from culture plates by activation of proteinase. Proc Natl Acad Sci U S A. 1978;75:459-463.
10. Katz SI, Halprin KM, Inderbitzin TM. The use of human skin for the detection of anti-epithelial autoantibodies: a diagnostic and prognostic test. J Invest Dermatol. 1969;53:390-399.
11. Beutner EH, Chorzelski TP, Jablonska S. Immunofluorescence tests: clinical significance of sera and skin in bullous diseases. Int J Dermatol. 1985;24: 405-421.
12. Ioannides D, Hytiroglou P, Phelps RG, Bystryn JC. Regional variation in the expression of pemphigus foliaceus, pemphigus erythematosus, and pemphigus vulgaris antigens in human skin. J Invest Dermatol. 1991;159:159-161.
13. Jiao D, Bystnyn JC. Sensitivity of indirect immunofluorescence substrate specificity, and immunoblotting in the diagnosis of pemphigus. J Am Acad Dermatol. 1997;37:211-216.
14. Stanley JR, Yaar M, Hawley-Nelson P, Katz SI. Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse keratinocytes. J Clin Invest. 1982;70:281-288.
15. Hashimoto T, Ogawa MM, Konohana A, Nishikawa T. Detection of pemphigus vulgaris and pemphigus foliaceus antigens by immunoblot analysis using different antigen sources. J Invest Dermatol. 1990;94:327-331.
16. Ishii K, Amagai M, Hall RP, et al. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J Immunol. 1997;159: 2010-2017.
17. Wang X, Ooi BG, Miller LK. Baculovirus vectors for multiple gene expression and for occluded virus production. Gene. 1991;100:131-137.
18. Amagai M, Ishii K, Hashimoto T, Gamou S, Shimizu N, Nishikawa T. Conformational epitopes of pemphigus antigens (Dsg1 and Dsg3) are calcium dependent and glycosylation independent. J Invest Dermatol. 1995;105:243-247.
19. Stanley JR, Koulu L, Klaus-Kovtun V, Steinberg MS. A monoclonal antibody to the desmosomal glycoprotein desmoglein I binds the same polypeptide as human autoantibodies in pemphigus foliaceus. J Immunol. 1986;136:1227-1230.
20. Amagai M, Hashimoto T, Green KJ, Shimizu N, Nishikawa T. Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. J Invest Dermatol. 1995;104:895-901.
21. Anhalt GJ, Emery DJ, Diaz LA, et al. Pemphigus foliaceus and pemphigus vulgaris auto antibodies react with the extracellular domain of desmoglein-1. J Invest Dermatol. 1995;104:323-328.
22. Kim SC, Kwon YD, Lee IJ, Lee IJ, Chang SN, Lee TG. Cloning of the 210-kDa paraneoplastic pemphigus antigen reveals that envoplacin is a component of the antigen complex. J Invest Dermatol. 1997;109:365-369.
23. Anhalt GJ, Kim SC, Stanley JR, et al. Paraneoplastic pemphigus: an autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med. 1990: 323:1729-1735.
24. Hashimoto T, Amagai M, Watanabe K, et al. Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis. J Invest Dermatol. 1995;104: 829-834.
25. Joly P, Thomine E, Gilbert D, et al. Overlapping distribution of auto antibody specificities in paraneoplastic pemphigus and pemphigus vulgaris. J Invest Dermatol. 1994;103:65-72.
26. Amagai M, Nishikawa T, Nousari HC, et al. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. J Clin Invest. 1998; 15:775-782.
27. Ahmed RA, Workman S. Anti-intercellular substance antibodies: presence in serum of 14 patients without pemphigus. Arch Dermatol. 1983;119:17-21.
28. Wolff K, Schreiner E. Ultrastructural localization of pemphigus autoantibodies within the epidermis. Nature. 1971;229:59-60.
29. Hashimoto T, Amagai M, Watanaba K, et al. A case of pemphigus vulgaris showing reactivity with pemphigus antigens (Dsg1 and Dsg3) and desmocollins. J Invest Dermatol. 1995;104:541-544.
30. Mahoney MG, Wang Z, Rothenberger KL, et al. Explanation for localization of blisters in pemphigus patients [abstract]. J Invest Dermatol. 1998;110:499.
31. Acosta E, Gilkes JJ, Ivanyi L. Relationship between the serum autoantibody titers and the clinical activity of pemphigus vulgaris. Oral Surg Oral Med Oral Pathol. 1985;60:611-614.
32. O'Loughlin S, Goldman GC, Provost TT. Fate of pemphigus antibody following successful therapy: preliminary evaluation of pemphigus antibody determinations to regulate therapy. Arch Dermatol. 1978;114:1769-1772.
33. Ratnam KV, Byran KP. Pemphigus in remission: value of negative direct immunofluorescence in management. J am Acad Dermatol. 1994;30:547-550.